ORSNES PATENT ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  7.4% 7.5% 9.8% 12.0% 20.7%  
Credit score (0-100)  33 31 24 19 5  
Credit rating  BB BB BB BB B  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Gross profit  1,924 1,991 1,282 1,114 626  
EBITDA  737 656 -78.2 -287 -824  
EBIT  737 656 -78.2 -287 -824  
Pre-tax profit (PTP)  731.9 651.2 -79.9 -286.9 -840.5  
Net earnings  570.9 507.9 -62.4 -223.8 -655.6  
Pre-tax profit without non-rec. items  732 651 -79.9 -287 -840  

 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  1,008 915 353 129 -526  
Interest-bearing liabilities  0.0 0.0 179 179 112  
Balance sheet total (assets)  1,437 1,329 753 531 2,466  

Net Debt  -842 -498 -94.0 20.8 -2,257  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  1,924 1,991 1,282 1,114 626  
Gross profit growth  -16.2% 3.5% -35.6% -13.1% -43.8%  
Employees  0 0 0 0 2  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,437 1,329 753 531 2,466  
Balance sheet change%  -5.6% -7.5% -43.3% -29.5% 364.4%  
Added value  737.2 655.9 -78.2 -286.9 -823.8  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 -1.0 -2.0 -3.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  38.3% 32.9% -6.1% -25.7% -131.5%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  49.8% 47.4% -7.5% -44.7% -46.7%  
ROI %  65.7% 68.2% -10.8% -68.2% -391.2%  
ROE %  50.9% 52.8% -9.8% -92.8% -50.5%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  70.1% 68.9% 46.9% 24.3% -17.6%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -114.2% -76.0% 120.1% -7.2% 274.0%  
Gearing %  0.0% 0.0% 50.8% 138.8% -21.2%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 1.9% 0.0% 12.3%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  3.3 3.2 1.9 1.3 0.8  
Current Ratio  3.3 3.2 1.9 1.3 0.8  
Cash and cash equivalent  841.8 498.4 273.4 158.7 2,368.5  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  1,007.5 915.4 353.0 129.3 -526.3  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 -412  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 -412  
EBIT / employee  0 0 0 0 -412  
Net earnings / employee  0 0 0 0 -328